TY - JOUR
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Analgesics, Opioid/adverse effects
KW - Attitude to Health
KW - Chronic Disease/psychology/therapy
KW - Female
KW - Humans
KW - Male
KW - Mass Screening/methods
KW - Middle Aged
KW - Opioid-Related Disorders/diagnosis/prevention & control/psychology
KW - Pain, Intractable/drug therapy/psychology
KW - Predictive Value of Tests
KW - Psychometrics/methods/standards
KW - Reproducibility of Results
KW - Risk Assessment/methods
KW - Risk Factors
KW - ROC Curve
KW - Surveys and Questionnaires/standards
AU - S. F. Butler
AU - K. Fernandez
AU - C. Benoit
AU - S. H. Budman
AU - R. N. Jamison
A1 - 
AB - UNLABELLED: The original Screener and Opioid Assessment for Patients with Pain (SOAPP) is a conceptually derived self-report questionnaire designed to predict aberrant medication-related behaviors among chronic pain patients considered for long-term opioid therapy. The purpose of this study was to develop and validate an empirically derived version of the SOAPP (SOAPP-R) that addresses some limitations of the original SOAPP. In successive steps, items were reduced from an initial pool of 142 to a 97-item beta version. The beta version was administered to 283 chronic pain patients receiving long-term opioid therapy. Items were evaluated based on data collected at follow-up, including correlation with the Aberrant Drug Behavior Index (ADBI), derived from interview data, physician ratings, and urine toxicology screens. Twenty-four items were retained and comprise the final SOAPP-R. Coefficient alpha was .88, and receiver operating characteristics curve analysis yielded an area under the curve of .81 (P < .001). A cutoff score of 18 showed adequate sensitivity (.81) and specificity (.68). The obtained psychometrics, along with the use of a predictive criterion that goes beyond self-report, suggest that the SOAPP-R is an improvement over the original version in screening risk potential for aberrant medication-related behavior among persons with chronic pain. PERSPECTIVE: There is a need for a screener for abuse risk in patients prescribed opioids for pain. This study presents a revised version of the SOAPP-R that is empirically derived with good reliability and validity but is less susceptible to overt deception than the original SOAPP version 1.
BT - The journal of pain : official journal of the American Pain Society
C5 - Opioids & Substance Use; Measures
CP - 4
CY - United States
DO - 10.1016/j.jpain.2007.11.014
IS - 4
JF - The journal of pain : official journal of the American Pain Society
N2 - UNLABELLED: The original Screener and Opioid Assessment for Patients with Pain (SOAPP) is a conceptually derived self-report questionnaire designed to predict aberrant medication-related behaviors among chronic pain patients considered for long-term opioid therapy. The purpose of this study was to develop and validate an empirically derived version of the SOAPP (SOAPP-R) that addresses some limitations of the original SOAPP. In successive steps, items were reduced from an initial pool of 142 to a 97-item beta version. The beta version was administered to 283 chronic pain patients receiving long-term opioid therapy. Items were evaluated based on data collected at follow-up, including correlation with the Aberrant Drug Behavior Index (ADBI), derived from interview data, physician ratings, and urine toxicology screens. Twenty-four items were retained and comprise the final SOAPP-R. Coefficient alpha was .88, and receiver operating characteristics curve analysis yielded an area under the curve of .81 (P < .001). A cutoff score of 18 showed adequate sensitivity (.81) and specificity (.68). The obtained psychometrics, along with the use of a predictive criterion that goes beyond self-report, suggest that the SOAPP-R is an improvement over the original version in screening risk potential for aberrant medication-related behavior among persons with chronic pain. PERSPECTIVE: There is a need for a screener for abuse risk in patients prescribed opioids for pain. This study presents a revised version of the SOAPP-R that is empirically derived with good reliability and validity but is less susceptible to overt deception than the original SOAPP version 1.
PP - United States
PY - 2008
SN - 1526-5900; 1526-5900
SP - 360
EP - 372
EP - 
T1 - Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R)
T2 - The journal of pain : official journal of the American Pain Society
TI - Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R)
U1 - Opioids & Substance Use; Measures
U2 - 18203666
U3 - 10.1016/j.jpain.2007.11.014
VL - 9
VO - 1526-5900; 1526-5900
Y1 - 2008
ER -